# Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma

> **NCT07713901** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 93600000 (estimated)

## Conditions studied

- Medullary Thyroid Carcinoma

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT07713901
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 93600000 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07713901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07713901, "Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07713901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*